XML 220 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Shareholders Equity - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non- Controlling Interests
Beginning balance at Dec. 31, 2020 $ 9,755.2 $ 3.8 $ 872.8 $ 10,511.0 $ (1,806.2) $ 173.8
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2020   379,100,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) 1,547.5     1,630.6 (85.6) 2.5
Stock Issued During Period, Shares, Restricted Stock Award, Gross   800,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (11.3)   (11.3)      
Stock based compensation $ 26.4   $ 26.4      
The total intrinsic value of options exercised during the fiscal year 3,200,000   3,200,000      
Stock Repurchased During Period, Shares   (11,200,000)        
Stock Repurchased During Period, Value $ (410.9) $ 0.1 $ (410.8)      
Dividends, Common Stock, Cash (127.4)     (127.4)    
Dividends for noncontrolling interests (31.3)         (31.3)
Noncontrolling Interest, Increase from Subsidiary Equity Issuance (2.9)   2.3     0.6
Ending balance at Dec. 31, 2021 $ 10,748.5 $ 3.7 478.0 12,014.2 (1,891.8) 144.4
Common stock shares outstanding, ending balance (in shares) at Dec. 31, 2021   368,700,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends per share (in usd per share) $ 0.30          
Total comprehensive income (loss) $ 3,355.6     3,582.8 (260.4) 33.2
Stock Issued During Period, Shares, Restricted Stock Award, Gross   1,200,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (19.2)   (19.2)      
Stock based compensation $ 31.5   $ 31.5      
The total intrinsic value of options exercised during the fiscal year 16,000,000.0   16,000,000.0      
Stock Repurchased During Period, Shares (30,810,173) (30,800,000)        
Stock Repurchased During Period, Value $ (1,673.2) $ 0.3 $ (506.3) (1,166.6)    
Dividends, Common Stock, Cash (227.0)     (227.0)    
Dividends for noncontrolling interests (38.0)         (38.0)
Ending balance at Dec. 31, 2022 $ 12,194.2 $ 3.4 0.0 14,203.4 (2,152.2) 139.6
Common stock shares outstanding, ending balance (in shares) at Dec. 31, 2022 339,071,423 339,100,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends per share (in usd per share) $ 0.60          
Total comprehensive income (loss) $ 1,408.5     1,164.9 197.3 46.3
Stock Issued During Period, Shares, Restricted Stock Award, Gross   1,900,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition $ (54.2)   (0.8) (53.4)    
Stock based compensation     33.0      
The total intrinsic value of options exercised during the fiscal year 33,000,000.0          
Stock Repurchased During Period, Shares (16,879,059) (16,900,000)        
Stock Repurchased During Period, Value $ (754.4) $ 0.2 (32.2)      
Dividends, Common Stock, Cash (351.0)     (351.0)    
Noncontrolling Interest, Increase from Subsidiary Equity Issuance (43.3)         43.3
Ending balance at Dec. 31, 2023 $ 12,432.8 $ 3.2 $ 0.0 14,241.9 $ (1,954.9) $ 142.6
Common stock shares outstanding, ending balance (in shares) at Dec. 31, 2023 324,103,141 324,100,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock Repurchased and Retired During Period, Value       $ (722.0)    
Dividends per share (in usd per share) $ 0.85          
Excised Tax on Share Repurchases $ 6.4